Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Eastern Piedmont Amadeo Avogadro
Vercelli, ItaliaPublicaciones en colaboración con investigadores/as de University of Eastern Piedmont Amadeo Avogadro (18)
2024
-
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy
Journal of Vascular and Interventional Radiology, Vol. 35, Núm. 9, pp. 1253-1267.e1
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network
European Journal of Cancer, Vol. 196
2023
2022
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
2021
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983
-
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer
Clinical and Translational Radiation Oncology, Vol. 23, pp. 91-99
-
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer
Radiotherapy and Oncology, Vol. 148, pp. 57-64
-
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Hepatology, Vol. 72, Núm. 1, pp. 198-212
2018
-
Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73
2017
-
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
Leukemia, Vol. 31, Núm. 1, pp. 107-114
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
American Journal of Hematology, Vol. 89, Núm. 4, pp. 355-362
-
Pomegranate (Punica granatum L.) expresses several nsLTP isoforms characterized by different immunoglobulin E-binding properties
International Archives of Allergy and Immunology, Vol. 164, Núm. 2, pp. 112-121
2013
-
Clinical and technical characteristics of intraoperative radiotherapy: Analysis of the ISIORT-Europe database
Strahlentherapie und Onkologie